News on hematology and coagulation testing systems and applications.
The company said that the funds will allow it to take its ReadyPlex rapid blood group genotyping assays into clinical trials and commercialization.
The firm's president of global diagnostics marketing said that recent revenue growth comes as a result of multiple initiatives implemented in recent years.
Under the 10-year deal, CoLabs will have access to Immucor's automated instrumentation and data-management technology.
Streck has inked a distribution agreement with Innovative Medical Solutions for its portfolio of controls, cell stabilization, and molecular products.
The commercial future of the test is uncertain, but one of its developers said that work to develop it demonstrates even mature technologies can have new clinical value.
